Table 2.
Bioactive compounds, efficacy and edibility of selected medicinal mushrooms.
| Source | Bioactive Compounds | Efficacy | Edible/Toxic |
|---|---|---|---|
| T. versicolor [91] | PSK, PSP | Cell-cycle arrest, affects apoptotic pathways, increases ROS | Edible [92] |
| G. lucidum [77] | Triterpenoids, polysaccharides | Immunomodulation, antioxidation, anti-proliferative, pro-apoptotic, and anti-angiogenic functions | Edible [93] |
| M. lobayensis [62] | PSPC | Antitumour and immunomodulatory effect | Edible [94] |
| P. ferulae [53] | PFPS | Immunomodulation, tumour growth inhibition | Edible [93] |
| F. velutipes [69] | FIP-fve | Induces CD8+ T-cell immune responses | Edible [93] |
| C. sinensis [95] | Cordycepin, polysaccharides, sterols | Antitumour and immunomodulatory effect | Edible [96] |
| P. ostreatus [88] | Ergosterol peroxide | Radiosensitizer | Edible [93] |
| L. squarrosulus [89] | Purified peptide | Increases cisplatin-induced cytotoxicity | Edible [97] |
PSK: polysaccharide-K; PSP: polysaccharopeptide; ROS: reactive oxygen species; PSPC: polysaccharide-protein complex; PFPS: Pleurotus ferulae polysaccharides; FIP-fve: fungal immunomodulatory protein.